EP2758407A1 - An improved process for cefpodoxime acid - Google Patents
An improved process for cefpodoxime acidInfo
- Publication number
- EP2758407A1 EP2758407A1 EP12784684.8A EP12784684A EP2758407A1 EP 2758407 A1 EP2758407 A1 EP 2758407A1 EP 12784684 A EP12784684 A EP 12784684A EP 2758407 A1 EP2758407 A1 EP 2758407A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- acid
- amino
- reaction mixture
- stirred
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract description 83
- LTINZAODLRIQIX-FBXRGJNPSA-N cefpodoxime proxetil Chemical compound N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC)C(=O)OC(C)OC(=O)OC(C)C)C(=O)C(=N/OC)\C1=CSC(N)=N1 LTINZAODLRIQIX-FBXRGJNPSA-N 0.000 title claims abstract description 58
- 229960004797 cefpodoxime proxetil Drugs 0.000 title claims abstract description 58
- HSHGZXNAXBPPDL-HZGVNTEJSA-N 7beta-aminocephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H]([NH3+])[C@@H]12 HSHGZXNAXBPPDL-HZGVNTEJSA-N 0.000 claims abstract description 38
- 238000002360 preparation method Methods 0.000 claims abstract description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 240
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 139
- 239000011541 reaction mixture Substances 0.000 claims description 102
- WIQPRUJPEDLQII-NPWHJSNTSA-N (6R)-7-amino-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-4-carboxylic acid Chemical compound NC1[C@@H]2N(C=C(C(S2)C(=O)O)COC)C1=O WIQPRUJPEDLQII-NPWHJSNTSA-N 0.000 claims description 50
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 41
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 38
- WRECIMRULFAWHA-UHFFFAOYSA-N trimethyl borate Chemical compound COB(OC)OC WRECIMRULFAWHA-UHFFFAOYSA-N 0.000 claims description 21
- 239000000706 filtrate Substances 0.000 claims description 13
- 238000001914 filtration Methods 0.000 claims description 13
- 239000007787 solid Substances 0.000 claims description 13
- DUYAAUVXQSMXQP-UHFFFAOYSA-M thioacetate Chemical compound CC([S-])=O DUYAAUVXQSMXQP-UHFFFAOYSA-M 0.000 claims description 13
- 150000007530 organic bases Chemical class 0.000 claims description 12
- 229910021529 ammonia Inorganic materials 0.000 claims description 10
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 claims description 9
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 claims description 5
- KYVBNYUBXIEUFW-UHFFFAOYSA-N 1,1,3,3-tetramethylguanidine Chemical compound CN(C)C(=N)N(C)C KYVBNYUBXIEUFW-UHFFFAOYSA-N 0.000 claims description 3
- 229940043279 diisopropylamine Drugs 0.000 claims description 3
- BGGJYTKJAIKDGT-HUASBAKNSA-N (6R)-7-amino-3-methoxy-4-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-4-carboxylic acid Chemical compound NC1[C@@H]2N(C=C(C(S2)(C(=O)O)C)OC)C1=O BGGJYTKJAIKDGT-HUASBAKNSA-N 0.000 claims description 2
- 239000003586 protic polar solvent Substances 0.000 claims description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 1
- 238000010791 quenching Methods 0.000 claims 1
- 230000000171 quenching effect Effects 0.000 claims 1
- ZFCQDZKQFPEDJE-UHFFFAOYSA-N thiolane 1,1-dioxide trifluoroborane Chemical compound S1(=O)(=O)CCCC1.B(F)(F)F ZFCQDZKQFPEDJE-UHFFFAOYSA-N 0.000 claims 1
- 238000003556 assay Methods 0.000 description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 44
- 229940086542 triethylamine Drugs 0.000 description 39
- 238000003756 stirring Methods 0.000 description 35
- 235000011114 ammonium hydroxide Nutrition 0.000 description 34
- 239000002253 acid Substances 0.000 description 31
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 27
- 238000006243 chemical reaction Methods 0.000 description 27
- 239000000203 mixture Substances 0.000 description 26
- XZVBIIRIWFZJOE-UHFFFAOYSA-N 1-iodoethyl propan-2-yl carbonate Chemical compound CC(C)OC(=O)OC(C)I XZVBIIRIWFZJOE-UHFFFAOYSA-N 0.000 description 24
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 24
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 24
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 24
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 22
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 21
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 20
- 229910015900 BF3 Inorganic materials 0.000 description 20
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 17
- BDSDFCVDQUGOFB-XNCJUZBTSA-N (6s,7s)-7-amino-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound S1CC(COC)=C(C(O)=O)N2C(=O)[C@H](N)[C@H]12 BDSDFCVDQUGOFB-XNCJUZBTSA-N 0.000 description 13
- CBHOOMGKXCMKIR-UHFFFAOYSA-N azane;methanol Chemical compound N.OC CBHOOMGKXCMKIR-UHFFFAOYSA-N 0.000 description 13
- 125000004190 benzothiazol-2-yl group Chemical group [H]C1=C([H])C([H])=C2N=C(*)SC2=C1[H] 0.000 description 12
- 238000010926 purge Methods 0.000 description 8
- 238000010626 work up procedure Methods 0.000 description 6
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 5
- -1 1-isopropoxycarbonyloxyethyl Chemical group 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 229950000033 proxetil Drugs 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000001117 sulphuric acid Substances 0.000 description 3
- 235000011149 sulphuric acid Nutrition 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 2
- VMPVEPPRYRXYNP-UHFFFAOYSA-I antimony(5+);pentachloride Chemical compound Cl[Sb](Cl)(Cl)(Cl)Cl VMPVEPPRYRXYNP-UHFFFAOYSA-I 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- JBXYCUKPDAAYAS-UHFFFAOYSA-N methanol;trifluoroborane Chemical compound OC.FB(F)F JBXYCUKPDAAYAS-UHFFFAOYSA-N 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- BDSDFCVDQUGOFB-SVGQVSJJSA-N (6r,7r)-7-amino-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound S1CC(COC)=C(C(O)=O)N2C(=O)[C@@H](N)[C@@H]12 BDSDFCVDQUGOFB-SVGQVSJJSA-N 0.000 description 1
- KLSJWNVTNUYHDU-UHFFFAOYSA-N Amitrole Chemical compound NC1=NC=NN1 KLSJWNVTNUYHDU-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 102100032373 Coiled-coil domain-containing protein 85B Human genes 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 101000868814 Homo sapiens Coiled-coil domain-containing protein 85B Proteins 0.000 description 1
- 241001072332 Monia Species 0.000 description 1
- 239000004133 Sodium thiosulphate Substances 0.000 description 1
- GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- YSVZGWAJIHWNQK-UHFFFAOYSA-N [3-(hydroxymethyl)-2-bicyclo[2.2.1]heptanyl]methanol Chemical compound C1CC2C(CO)C(CO)C1C2 YSVZGWAJIHWNQK-UHFFFAOYSA-N 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 1
- 125000003460 beta-lactamyl group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- QSLUWZMIMXNLJV-UHFFFAOYSA-L calcium methanol dichloride Chemical compound [Cl-].[Cl-].[Ca+2].OC QSLUWZMIMXNLJV-UHFFFAOYSA-L 0.000 description 1
- 229960005090 cefpodoxime Drugs 0.000 description 1
- WYUSVOMTXWRGEK-HBWVYFAYSA-N cefpodoxime Chemical compound N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC)C(O)=O)C(=O)C(=N/OC)\C1=CSC(N)=N1 WYUSVOMTXWRGEK-HBWVYFAYSA-N 0.000 description 1
- YGBFLZPYDUKSPT-MRVPVSSYSA-N cephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)C[C@H]21 YGBFLZPYDUKSPT-MRVPVSSYSA-N 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- OPGQKSHKFCOBGF-UHFFFAOYSA-N methanesulfonic acid;methanol Chemical compound OC.CS(O)(=O)=O OPGQKSHKFCOBGF-UHFFFAOYSA-N 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- RBLVMKIXRXHOLI-UHFFFAOYSA-M sodium;hydrogen carbonate;methanol Chemical compound [Na+].OC.OC([O-])=O RBLVMKIXRXHOLI-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
- C07D501/28—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by an aliphatic carboxylic acid, which is substituted by hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
- C07D501/06—Acylation of 7-aminocephalosporanic acid
Definitions
- the present invention relates to an improved process for the preparation of cefpodoxime acid.
- cefpodoxime proxetil is 1-isopropoxycarbonyloxyethyl (6R,7R)-7-[2-(2- aminothiazol-4-yl)-2-(Z)-(methoxyimino)acetamido]-3-(methoxymethyl)-3-ceohem-4- carboxylate of formula (IV )and is disclosed in U.S Patent No 4,486,425.
- Cefpodoxime acid is a precursor of cefpodoxime proxetil.
- cefpodoxime acid is prepared from 7-Amino cephalosporanic acid in two steps .
- 7-Amino -3-methoxymethyl-3-cephem-4- carboxylic acid of formula(I) is derivative of 7-Amino cephalosporanic acid (II) and there have been reported many method for the preparation thereof starting from 7- Aminocephalosporanic acid of formula(II).
- cefbodoxime acid is [(6R-[6a,7P(Z)]-7-[2-(2-aminothiazol-4-yl)-2- metthoxyimino)acetamido]-3-cephem-4-carboxylic acid having formula( III), and is known from U.S.Pat.No. 4,409,215.
- Cefpodoxime acid is prepared by condensation of 7-Amino -3-methoxymethyl-3-cephem- 4-carboxylic acid (i)with Benzothiazo ⁇ -2- ⁇ (Z)-2-methoxyimino-2-(2-atninothiazoie-4-yl) thioacetate (MAEM) in water miscible solvent under basic condition
- Cefpodoxime acid is not suitable for oral administration, its ester derivative, 1- (isopropoxycarbonyloxyl)ethyl ester i.e Cefbodoxime proxetil of formula (IV) is used in the treatment.
- 7-Amino-3-methoxymethyl-3-cephem-4-carboxylic acid of formula(I) is a precursor of cefpodoxime proxetil, and there have been reported many methods for the preparation thereof starting from 7-aminocephalosphoranic acid (7-ACA) of formula (II).
- JP Patent No. 82,192,392 and U.S.patent.No. 4,482,710 teaches preparation of 7-Amino 3- methoxy methyl-3-cephem carboxylic acid by the step of protecting the 7-amino group of 7- ACA with a phenylacetyl group; converting the 3-acetoxy group to a methoxy group by the action of methanol-sodium bicarbonate or methanol-calcium chloride; and removing the protection group.
- this method has the problem that yield obtained are very low(approximately less then 20%) and the process requires multi-steps.
- JP Patent No . 84,163,387 teaches a method of preparing 7-Amino3-methoxymethyl-3- cephem-4-carboxylic acid by treating 7-Amino cephalosporanic acid with methane sulphonic acid -methanol.
- this method also has the problem of low yield(approximately 30%) , and the product purity is poor(approximately 30 to40%) due to the formation of by-product such as lactone or the degradition material of the ⁇ -lactam ring.
- EP Patent 262,744 discloses a method of preparing 7-amino-3-methoxymethyl-3- cephem-4-carboxylic acid by reacting 7-ACA with methanol in the presence of a halide of antimony or zinc.
- this method is hampered by the problem of low yield (approximately 40%) and is not suitable for mass production due to use of column chromatography for separating final product.
- JP Patent No 88,115,887 discloses 7-amino-3-methoxymethyl-3-cephem-4- carboxylic acid has been prepared by treating 7-Amino cephalosporanic acid with boron trifluoride-methanol in presence of halo sulfonic acid or alkylsulfonic acid .
- EP. Patent No.343926 teaches a method of preparing 7-amino-3-methoxymethyl-3- cephem-4-carboxylic acid by reacting 7aminocephalosporanic acid with trimethyl borate in sulfolane, in the presence of sulphuric acid and antimony pentachloride.
- this method requires the use of expensive antimony pentachloride as well as 98% trimethyl borate which is difficult to handle.
- EP Patent No.485,204 reveals a method for preparing 7-amino-3-methoxymethyl-3- cephem-4-carboxylic acid by treating 7-ACA in a solution containing an alkoxysulfonic acid with a trialkyl borate and an alkylal.
- this method still has to deal with the difficulty of handling 98% trimethyl borate which is difficult to handle and also suffers from the problem of poor process controllability.
- An object of the present invention is to provide a process for preparation of 7-AMCA involving non-aqueous work up starting from 7-Amino cephalosporanic acid.
- Another object of the present invention is to provide a process for preparation of Cefpodoxime acid with enhanced yield from 7-AMCA.
- Yet another object of the present invention is to provide a process for preparation of Cefpodoxime Proxetil from cefpodoxime acid having an enhance yield and required purity.
- the present invention relates to a process for the preparation of 7-AMCA implementing a non-aqueous work up of the reaction mixture involving treating with two different organic bases in two stages, which is further converted to Cefpodoxime acid with an enhanced yield by conventional method.
- the invention also provides a process for the preparation of Cefpodoxime proxetil with an enhanced yield.
- present invention relates to an improved process for the preparation Cefpodoxime acid comprising steps of reacting 7-Amino cephalosporanic acid ( 7ACA) with a mixture of methane sulphonic acid and methanol or Methane sulphonic acid , Methanol , trimethylborate or sulpholane , BF3 , Methanol at a temperature ranging between 5°C-50°C, followed by addition of calculated amount of methanol.
- 7ACA 7-Amino cephalosporanic acid
- the reaction mixture stirred for 1- 2hours around 5-50°C and worked up by first adjusting the to pH to a value of around 0.5 with methanolic solution of first organic base and then filtering the precipitated solid, followed by adjusting the pH of the filtrate to 3.3 to 3.5 using second organic base .
- the precipitated 7-Amino 3-methoxymethyl 3-cephem carboxylic acid thus obtained is further converted into Cefpodoxime acid having required purity and enhanced yield by adopting conventional method reported in prior art.
- Cefpodoxime acid is converted into Cefpodoxime Proxetil with improved yield by any of the conventional method known in the prior art.
- An embodiment of the present invention provides a process in which non-aqueous work up is performed for the preparation of 7-AMCA.
- Another embodiment of the present invention provides a process for the preparation of Cefpodoxime acid with enhanced yield.
- Yet another embodiment of the present invention uses two organic bases in a specific sequential order to obtain 7-AMCA.
- Still yet another embodiment of the present invention provides a process for the preparation of Cefpodoxime acid from 7-AMCA having enhanced yield and required purity.
- Another embodiment of the present invention where in the first organic base used for adjusting the pH of the reaction mixture is ammonia in methanol. Yet another embodiment of the present invention wherein the second organic base used for adjusting the pH is selected from triethylamine, diethyl amine, di isopropyl amine and tetramethyl guanidine. Still another r embodiment of present invention provides a process for the conversion of cefpodoxime acid in to cefpodoxime proxetil having an enhance yield.
- step A 7-Amino 3-methoxymethyl 3-cephem carboxylic acid (300gm) Obtained in step A above is taken in a aqueous methanol and cooled to 15-20°C and treated with Benzothiazol-2-yl (Z)"2-methoxyimino-2-(2-aminothiazole ⁇ 4 ⁇ yl)thioaceiate (MAEM) in presence of Tri ethyl amine and stirred further for 5-6 hours. The reaction mixture is quenched by adding water, adjusting the pH to around 5.5 to 6.0 by using dilute sulphuric acid ..
- reaction mixture was worked up by adding Hydrochloric acid (2ml) in (20) ml water maintaining the temperature in the range of -15-10°C.Then Reaction mass is transferred in to mixture of ethyl acetate (200 ml), water 400 ml and Sodium thio sulphate (4.0gm) at 10-15°C . stirred the mass for lOmin , separate the layers. Aqueous layer washed with 100 ml Ethyl acetate . Combined both ethyl acetate layer and washed thrice with 150 ml 10% sodium chloride solution at 15°C. Ethyl acetate layer was treated with activated carbon.
- Example (2) (A)Added 7-Amino cephalosporanic acid (100gm,0.3676 mol) is added to a mixture of methane sulphonic acid(500ml) and methanol(155ml) at a temperature ranging between 5°- 10°C. The reaction mixture stirred for l-2hours around 10-12° and quenched the reaction mass by adding it to chilled water (1000ml) . Added cone triethyl amine (780gm) slowly over a period of 60-75min maintaining the temperature in the range of 0-lOC to attain a pH value of around 0.5 followed by adjusting the pH of the solution to 3.3 to 3.5. The precipitated 7-Amino 3-methoxymethyl 3-cephem carboxylic acid(7-AMCA) is isolated(wet yield— 320gm).
- step A 7-Amino 3-methoxymethyl 3-cephem carboxylic acid (320gm) Obtained in step A above is taken in a aqueous methanol and cooled to 15-20°C and treated with Benzothiazo i-2-yi (/ ) ⁇ 2"meihoxyimino ⁇ 2 ⁇ (2"aminoihiazole ⁇ ⁇ yl) ⁇ hioaceiaie (MAEM) in presence of Tri ethyl amine and stirred further for 5-6 hours. The reaction mixture is quenched by adding water and further worked up following the procedure as described in example 1 step (B).
- Example (3) (A)Added 7-Amino cephalosporanic acid (100gm,0.3676 mol) is added to mixture of methane sulphonic acid(500ml) and methanol(155ml) at a temperature ranging between 5°- 10°C. The reaction mixture stirred for l-2hours around 10-12° and quenched the reaction mass by adding it to chilled methano 1(1000ml). Added methanolic ammonia solution (126 gm in 1000ml) slowly over a period of 60-75min maintaining the temperature in the range of 0-lOC to achieve pH value of around 0.5, Filtering the precipitated solid, followed by adjusting the pH of the filtrate to 3.3 to 3.5 by treating with methanolic ammonia solution. The precipitated 7-Amino 3-methoxymethyl 3-cephem carboxylic acid(7-AMCA) is isolated(wet yield— 230gm).
- step A 7-Amino 3-methoxymethyl 3-cephem carboxylic acid (230gm) Obtained in step A above is taken in a aqueous methanol and cooled to 15-20°C and treated with
- reaction mixture was stirred for 30 min .
- the reaction mixture was worked up following the procedure as described in example 1 step (C). ( Yield 23.8gm, Assay 91.5% )
- step A 7-Amino 3-methoxymethyl 3-cephem carboxylic acid (250gm) Obtained in step A above is taken in a aqueous methanol and cooled to 15-20°C and treated with Benzothiazol-2-yl
- step A 7-Amino 3-methoxymethyl 3-cephem carboxylic acid (160gm) Obtained in step A above is taken in a aqueous methanol and cooled to 15-20°C and treated with Benzothiazol-2-yl (Z)-2-methoxyimino-2-(2-aminoth1 ⁇ 4zole-4-yl)th.ioacetate (MAEM) in presence of Tri ethyl amine and stirred further for 5-6 hours. The reaction mixture is quenched by adding water and further worked up following the procedure as described in example 1 step (B).
- step A 7-Amino 3 -methoxymethyl 3-cephem carboxylic acid (320gm) Obtained in step A above is taken in a aqueous methanol and cooled to 15-20°C and treated with Benzothiazol-2-yl (Z)-2-methoxyimino-2-(2-aminoth1 ⁇ 4zole-4-yl)th.ioacetate (MAEM) in presence of Tri ethyl amine and stirred further for 5-6 hours. The reaction mixture is quenched by adding water and further worked up following the procedure as described in example 1 step (B).
- step A 7-Amino 3-methoxymethyl 3-cephem carboxylic acid (180gm) Obtained in step A above is taken in a aqueous methanol and cooled to 15-20°C and treated with Benzothiazol-2-yl (Z)-2-inethoxyimmo-2-(2-arainothia2:ole-4-y].)thioacetate (MAEM) in presence of Tri ethyl amine and stirred further for 5-6 hours. The reaction mixture is quenched by adding water and further worked up following the procedure as described in example 1 step (B).
- step A ((B) 7- Amino 3-methoxymethyl 3-cephem carboxylic acid (350gm) Obtained in step A above is taken in a aqueous methanol and cooled to 15-20°C and treated with
- step A 7-Amino 3-methoxymethyl 3-cephem carboxylic acid (380gm) Obtained in step A above is taken in a aqueous methanol and cooled to 15-20°C and treated with Benzothiazo i-2-yi (Z)"2-meihoxyimino-2-(2-aminoihiazole ⁇ 4 ⁇ yl) ⁇ hioaceiate (MAEM) in presence of Tri ethyl amine and stirred further for 5-6 hours. The reaction mixture is quenched by adding water and further worked up following the procedure as described in example 1 step (B).
- step A 7- Amino 3-methoxymethyl 3-cephem carboxylic acid (290gm) Obtained in step A above is taken in a aqueous methanol and cooled to 15-20°C and treated with Benzothiazol-2-yl (Z) ⁇ 2 ⁇ metlioxyimino-2"(2 ⁇ amiiiotliiazole"4-yl)tliioacetate (MAEM) in presence of Tri ethyl amine and stirred further for 5-6 hours. The reaction mixture is quenched by adding water and further worked up following the procedure as described in example 1 step (B). (103gm,Assay 91.0%).
- step A 7-Amino 3-methoxymethyl 3-cephem carboxylic acid (320gm) Obtained in step A above is taken in a aqueous methanol and cooled to 15-20°C and treated with Benzothiazoi-2-yi (Z)"2-methoxyimino-2-(2-aminothiazole ⁇ 4 ⁇ yl)thioaceiate (MAEM) in presence of Tri ethyl amine and stirred further for 5-6 hours. The reaction mixture is quenched by adding water and further worked up following the procedure as described in example 1 step (B).
- step A 7-Amino 3-methoxymethyl 3-cephem carboxylic acid (190gm) Obtained in step A above is taken in a aqueous methanol and cooled to 15-20°C and treated with
- Example(13) A) 245ml of methane sulphonic acid was mixed with 60.0mlof an azeotropic mixture composed of 70% Trimethyl borate and 30% methanol and solution was cooled to 10°C. 7- amino cephalosporanic acid (100 gm, 0.3676 mole) was slowly added in 30min and dissolve completely. Then additional 63ml of trimethyl borate azeotropic mixture was added slowly in 80-90 meanwhile maintaining the temperature at 10-12°C. The reaction mixture stirred for 60-90min and quenched the reaction mass by adding it to chilled water (1000ml) .
- an azeotropic mixture composed of 70% Trimethyl borate and 30% methanol and solution was cooled to 10°C. 7- amino cephalosporanic acid (100 gm, 0.3676 mole) was slowly added in 30min and dissolve completely. Then additional 63ml of trimethyl borate azeotropic mixture was added slowly in 80-90 meanwhile maintaining the temperature at 10-12°C. The
- step A 7-Amino 3-methoxymethyl 3-cephem carboxylic acid (340gm) Obtained in step A above is taken in a aqueous methanol and cooled to 15-20°C and treated with
- Benzothiazo l-2-yl (Z)-2-methoxyimino-2-(2-aminothiazole-4-yl) thioacetate (MAEM) in presence of Tri ethyl amine and stirred further for 5-6 hours.
- the reaction mixture is quenched by adding water and further worked up following the procedure as described in example 1 step (B). (85gm,Assay 93.5%>).
- step A 7-Amino 3-methoxymethyl 3-cephem carboxylic acid (200gm) Obtained in step A above is taken in a aqueous methanol and cooled to 15-20°C and treated with Benzothiazol-2-yl (Z)-2-inethoxyimmo-2-(2-arainothia2:ole-4-y].)thioacetate (MAEM) in presence of Tri ethyl amine and stirred further for 5-6 hours. The reaction mixture is quenched by adding water and further worked up following the procedure as described in example 1 step (B).
- Example(15) 1000ml of sulpholane was mixed with 225 gm methanol . Purge 360 gm BF3 gas at 30- 40°C in 60-90 min . Then charge 7-amino cephalosporanic acid (100 gm,0.3676 mole) at 45°C in single lot. The reaction mixture stirred for 60-90min at 48-50°C and quenched the reaction mass by adding it to chilled water (1000 ml) . Charge 1000ml methylene chloride , stir 10 min at 30°C .Separate the layers. Again Charge 1000ml methylene chloride , stir 10 min at 30°C .Separate the layers.
- step A 7-Amino 3-methoxymethyl 3-cephem carboxylic acid (320gm) Obtained in step A above is taken in a aqueous methanol and cooled to 15-20°C and treated with
- Benzothiazoi-2-yi (MAEM) in presence of Tri ethyl amine and stirred further for 5-6 hours.
- the reaction mixture is quenched by adding water and further worked up following the procedure as described in example 1 step (B). (99gm,Assay 95.5%).
- step A 7- Amino 3-methoxymethyl 3-cephem carboxylic acid (300gm) Obtained in step A above is taken in a aqueous methanol and cooled to 15-20°C and treated with
- Benzothiazol-2-yl Z)-2-methoxyimino-2-(2-aniinothiazole'-4-yi)thioacetate (MAEM) in presence of Tri ethyl amine and stirred further for 5-6 hours.
- the reaction mixture is quenched by adding water and further worked up following the procedure as described in example 1 step (B). (100gm,Assay 97.5%).
- step A 7-Amino 3-methoxymethyl 3-cephem carboxylic acid (250gm) Obtained in step A above is taken in a aqueous methanol and cooled to 15-20°C and treated with Benzothiazoi-2-yi (Z)"2-methoxyimino-2-(2-aminothiazole ⁇ 4 ⁇ yl)thioaceiaie (MAEM) in presence of Tri ethyl amine and stirred further for 5-6 hours. The reaction mixture is quenched by adding water and further worked up following the procedure as described in example 1 step (B).
- step A The precipitated 7- Amino 3-methoxymethyl 3-cephem carboxylic acid(7-AMCA) is isolated(wet yield— 280gm).
- step B 7-Amino 3-methoxymethyl 3-cephem carboxylic acid (280 gm) Obtained in step A above is taken in a aqueous methanol and cooled to 15-20°C and treated with
- BenzothiazoI-2-yi (Z)"2 ⁇ methoxyimino ⁇ 2-(2 ⁇ aminotMazole ⁇ 4-yl)thioacetate (MAEM) in presence of Tri ethyl amine and stirred further for 5-6 hours.
- the reaction mixture is quenched by adding water and further worked up following the procedure as described in example 1 step (B). (101gm,Assay 94.2%).
- step A 7-Amino 3-methoxymethyl 3-cephem carboxylic acid (200 gm) Obtained in step A above is taken in a aqueous methanol and cooled to 15-20°C and treated with
- step (B) 7- Amino 3-methoxymethyl 3-cephem carboxylic acid (310gm) Obtained in step (A) above is taken in a aqueous methanol and cooled to 15-20°C and treated with
- Benzochiazo ⁇ -2-yi (Z)-2-meth.oxyimino-2-(2-ainmothia2'.oIe-4-yI) thioacetate (MAE ) in presence of Tri ethyl amine and stirred further for 5-6 hours.
- the reaction mixture is quenched by adding water and further worked up following the procedure as described in example 1 step (B). (87.0gm,Assay 94.5%).
- reaction mixture was stirred for 30 min .
- the reaction mixture was worked up following the procedure as described in example 1 step (C). ( Yield 24.00gm, Assay 94.0% )
- step (B) 7- Amino 3-methoxymethyl 3-cephem carboxylic acid (180 gm) Obtained in step (A) above is taken in a aqueous methanol and cooled to 15-20°C and treated with
- step A 7-Amino 3-methoxymethyl 3-cephem carboxylic acid (158gm) Obtained in step A above is taken in a aqueous methanol and cooled to 15-20°C and treated with Benzothiazol-2-yl (Z)"2-methoxyimino-2-(2-aminothiazole ⁇ 4 ⁇ yl)thioaceiate (MAEM) in presence of Tri ethyl amine and stirred further for 5-6 hours. The reaction mixture is quenched by adding water and further worked up following the procedure as described in example 1 step (B). (lOlgm, Assay 98.2%).
- step A 7-Amino 3-methoxymethyl 3-cephem carboxylic acid (180gm) Obtained in step A above is taken in a aqueous methanol and cooled to 15-20°C and treated with Benzothiazol-2-yl (Z)-2 » methoxyimino-2-(2 » amiiiothiazole-4-yl)thioacetate (MAEM) in presence of Tri ethyl amine and stirred further for 5-6 hours. The reaction mixture is quenched by adding water and further worked up following the procedure as described in example 1 step (B).
- step A 7-Amino 3-methoxymethyl 3-cephem carboxylic acid (190gm) Obtained in step A above is taken in a aqueous methanol and cooled to 15-20°C and treated with Benzothiazol-2-yl (Z)-2-methoxyiinino-2-(2-aminothia x)ie-4-yl)thioacetate (MAEM) in presence of Tri ethyl amine and stirred further for 5-6 hours. The reaction mixture is quenched by adding water and further worked up following the procedure as described in example 1 step (B).
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2718DE2011 | 2011-09-20 | ||
| PCT/IB2012/054602 WO2013041999A1 (en) | 2011-09-20 | 2012-09-06 | An improved process for cefpodoxime acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP2758407A1 true EP2758407A1 (en) | 2014-07-30 |
Family
ID=47178227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP12784684.8A Withdrawn EP2758407A1 (en) | 2011-09-20 | 2012-09-06 | An improved process for cefpodoxime acid |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP2758407A1 (en) |
| WO (1) | WO2013041999A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106046024B (en) * | 2016-06-30 | 2019-01-15 | 齐鲁动物保健品有限公司 | A kind of preparation method of Cefpodoxime Proxetil |
| CN106478666B (en) * | 2016-09-22 | 2018-07-31 | 湖北凌晟药业有限公司 | The preparation method of 7- amino -3- methoxyl methyl -3- cephem -4- carboxylic acids |
| CN112480144A (en) * | 2020-12-07 | 2021-03-12 | 湖北凌晟药业有限公司 | Preparation method of 7-amino-3-methoxymethyl-3-cephem-4-carboxylic acid |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4409215A (en) | 1979-11-19 | 1983-10-11 | Fujisawa Pharmaceutical Co., Ltd. | 7-Acylamino-3-substituted cephalosporanic acid derivatives and processes for the preparation thereof |
| US4486425A (en) | 1980-09-30 | 1984-12-04 | Sankyo Company Limited | 7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]-3-methoxymethyl-3-cephem-4-carboxylates |
| JPS57192392A (en) | 1981-05-19 | 1982-11-26 | Sankyo Co Ltd | Production of 3-alkoxymethylcephalosporin |
| JPS5896091A (en) | 1981-12-01 | 1983-06-07 | Sankyo Co Ltd | Preparation of 3-alkoxymethylcephalosporins |
| JPS59163387A (en) | 1983-03-07 | 1984-09-14 | Sankyo Co Ltd | Preparation of 3-alkoxymethylcephalosporin |
| AT384222B (en) | 1985-06-03 | 1987-10-12 | Biochemie Gmbh | METHOD FOR PRODUCING 7-AMINO-3ALKOXYMETHYL-3-CEPHEM-4-CARBONIC ACIDS |
| ES2061485T3 (en) | 1986-10-02 | 1994-12-16 | Asahi Chemical Ind | PROCEDURE FOR THE MANUFACTURE OF 3-ALCOXIMETILCEFALOSPORINAS. |
| JPS63115887A (en) | 1986-11-04 | 1988-05-20 | Asahi Chem Ind Co Ltd | Method for producing 7-amino-3-alkoxymethylcephalosporins |
| JP2612493B2 (en) | 1988-05-24 | 1997-05-21 | 旭化成工業株式会社 | Method for producing 3-substituted methyl-3-cephem-4-carboxylic acids |
| IE68511B1 (en) | 1990-11-07 | 1996-06-26 | Sankyo Co | Process for the preparation of 3-alkoxymethylcephalosporin derivatives |
| WO2004060896A1 (en) * | 2003-01-06 | 2004-07-22 | Lupin Limited | A process for the manufacture of cefpodoxime proxetil |
| WO2011077217A1 (en) * | 2009-12-21 | 2011-06-30 | Nectar Lifesciences Ltd. | An improved process for the preparation of cefpodoxime acid |
-
2012
- 2012-09-06 EP EP12784684.8A patent/EP2758407A1/en not_active Withdrawn
- 2012-09-06 WO PCT/IB2012/054602 patent/WO2013041999A1/en not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2013041999A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013041999A1 (en) | 2013-03-28 |
| WO2013041999A4 (en) | 2013-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102372728B (en) | Synthesizing method for cephalosporin compound | |
| US20060111566A1 (en) | Intermediate cefdinir salts | |
| WO2011042776A1 (en) | Process for preparation of cefotaxime acid and pharmaceutically acceptable salt thereof | |
| NO145918B (en) | PROCEDURE FOR THE PREPARATION OF 7-ACYLAMIDO-3-CEFEM-4-CARBOXYLIC ACIDS. | |
| EP2758407A1 (en) | An improved process for cefpodoxime acid | |
| EP1863822B1 (en) | An improved process for the preparation of cefixime | |
| WO2007122628A1 (en) | Improved process for preparation of highly pure cefotetan disodium | |
| WO2011077217A1 (en) | An improved process for the preparation of cefpodoxime acid | |
| CN102659817B (en) | Preparation method of cefdinir | |
| JP3751880B2 (en) | Method for producing high-purity cefpodoxime proxetil | |
| US7045618B2 (en) | Cefpodixime proxetil | |
| WO2011042775A1 (en) | Process for preparation of cefotaxime acid | |
| US20030199712A1 (en) | Process for the preparation of cephalosporin intermediate and its use for the manufacture of cephalosporin compounds | |
| AU755155B2 (en) | Process for preparing 7-amino-3-methoxymethyl-3-cephem-4-carboxylic acid | |
| CN101486720B (en) | Method for synthesizing cefodizime sodium compound | |
| WO2008041100A1 (en) | Improved process for the preparation of cephalosporin antibiotics | |
| US20060149055A1 (en) | Process for the manufacture of cefpodoxime proxetil | |
| US20060009639A1 (en) | Process for the preparation of cefpodoxime proxetil | |
| US20070004916A1 (en) | Process for the production of cefotaxime sodium | |
| WO2018229580A1 (en) | An improved process for the preparation of cefovecin sodium | |
| WO2011121389A1 (en) | Process for preparation of cefepime dihydrochloride monohydrate | |
| CN1962666A (en) | Cepham antibiotics and its intermediate preparation method | |
| KR100760429B1 (en) | Improved preparation of 2-aminothiazol-4-yl acetylchloride hydrochloride used as an intermediate for the preparation of cephalosporins | |
| JP2024503655A (en) | Method for producing high yield and high purity flomoxef | |
| CS203966B2 (en) | Method of preparing cephalosporins having free amino group in position 7 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20140417 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAX | Request for extension of the european patent (deleted) | ||
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: SRIVASTAVA, ALOK DHANUKA LABORATORIES LIMITED Inventor name: SINGH, SANDEEP DHANUKA LABORATORIES LIMITED Inventor name: DHANUKA, MANISH DHANUKA LABORATORIES LIMITED |
|
| 17Q | First examination report despatched |
Effective date: 20150727 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20151208 |